CMX001 for Prevention and Control of CMV Infection in CMV-Seropositive Allogeneic Stem-Cell Transplant Recipients: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial of Safety, Tolerability and Antiviral Activity

✍ Scribed by F.M. Marty; D. Winston; S.D. Rowley; M. Boeckh; E. Vance; G. Papanicolaou; A. Robertson; S. Godkin; W. Painter

• Book ID: 116282845
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 100 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.004